Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Medtronic
Colorcon
McKinsey
Harvard Business School

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

BOTOX COSMETIC Drug Profile

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: BOTOX COSMETIC
Recent Clinical Trials for BOTOX COSMETIC

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Azienda Ospedaliero-Universitaria CareggiPhase 2/Phase 3
Institut CuriePhase 2/Phase 3
University of FlorencePhase 2/Phase 3

See all BOTOX COSMETIC clinical trials

Pharmacology for BOTOX COSMETIC

Company Disclosures: US Patents for BOTOX COSMETIC

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 004 1991-12-09   Start Trial The Regents of the University of Colorado (Boulder, CO) 2017-07-15 RX company
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 004 1991-12-09   Start Trial Allergan, Inc. (Irvine, CA) 2013-12-28 RX company
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 004 1991-12-09   Start Trial Allergan, Inc. (Irvine, CA) 2013-12-28 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for BOTOX COSMETIC

These patents were identified by searching patent claims

Supplementary Protection Certificates for BOTOX COSMETIC

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
509 Finland   Start Trial
39/2013 Austria   Start Trial PRODUCT NAME: BOTULINUMTOXIN TYP A; REGISTRATION NO/DATE: 2-00358; 1-23699; 2-00381 20130117
C300564 Netherlands   Start Trial PRODUCT NAME: BOTULINUM TOXINE; NAT. REGISTRATION NO/DATE: RVG 32957RVG 17379RVG 32958 2012270627; FIRST REGISTRATION: NL 25449 20110822
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Dow
Boehringer Ingelheim
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.